These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 23333067)
1. Should all endometrioid uterine cancer patients undergo systemic lymphadenectomy? Wang ZQ; Wang JL; Shen DH; Li XP; Wei LH Eur J Surg Oncol; 2013 Apr; 39(4):344-9. PubMed ID: 23333067 [TBL] [Abstract][Full Text] [Related]
2. Impact of lymphadenectomy in uterine endometrioid carcinoma. Huang CY; Ho CM; Chen YL; You SL; Chen CA; Cheng WF Eur J Surg Oncol; 2013 Apr; 39(4):350-7. PubMed ID: 23462243 [TBL] [Abstract][Full Text] [Related]
3. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)]. Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656 [TBL] [Abstract][Full Text] [Related]
4. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy as a prognostic marker in uterine non-endometrioid carcinoma. Mylonas I; Schindlbeck C Arch Gynecol Obstet; 2012 Jan; 285(1):207-14. PubMed ID: 21538008 [TBL] [Abstract][Full Text] [Related]
6. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573 [TBL] [Abstract][Full Text] [Related]
7. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
10. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer. Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600 [TBL] [Abstract][Full Text] [Related]
11. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma]. Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691 [TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer. Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137 [TBL] [Abstract][Full Text] [Related]
13. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [TBL] [Abstract][Full Text] [Related]
14. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis. Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700 [TBL] [Abstract][Full Text] [Related]
15. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma. Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214 [TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study. Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682 [TBL] [Abstract][Full Text] [Related]
18. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB; Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838 [TBL] [Abstract][Full Text] [Related]
19. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311 [TBL] [Abstract][Full Text] [Related]
20. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]